Genetic variants in m6A regulator genes confer susceptibility and progression of HCC in a Northern Chinese population
Open Access
- 15 April 2025
- journal article
- research article
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 1-17
Abstract
Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality globally. While m6A regulators are implicated in cancer progression, the role of single nucleotide polymorphisms (SNPs) in m6A regulator genes in HCC susceptibility remains underexplored. Here, we evaluated 31 candidate SNPs across eight dysregulated m6A regulator genes in a case–control study comprising 800 HCC patients and 800 healthy controls from Northeast China. Genotyping revealed three SNPs significantly associated with elevated HCC risk: rs2736158 C allele (PRRC2A; adjusted odds ratio [OR] = 1.295, 95% [CI] = 1.039–1.615, p = 0.021), rs9366785 A allele (PRRC2A; adjusted odds ratio [OR] = 1.312, 95% [CI] = 1.011–1.704, p = 0.041), and rs274054 C allele (IGF2BP3; adjusted odds ratio [OR] = 1.224, 95% [CI] = 1.040–1.440, p = 0.015). Comparison of genotype frequency of three SNPs under given genetic models further linked rs274054 CC (IGF2BP3), rs2736158 CC (PRRC2A), and rs9366785 AA + AG (PRRC2A) genotypes to higher HCC risk. Subgroup analyses identified associations between specific genotypes (e.g., rs9906944 TT/TC in IGF2BP1) and adverse clinicopathological features, including vascular invasion and liver cirrhosis. Haplotype analysis highlighted the CACA haplotype (PRRC2A: rs280801, rs2736171, rs2736158, rs2736157) as a high-susceptibility marker (adjusted odds ratio [OR] = 1.297, 95% [CI] = 1.041–1.616, p = 0.020). Our findings suggest that m6A regulator SNPs contribute to HCC susceptibility and progression, offering insights into genetic biomarkers for risk stratification in Northeast Chinese populations.Keywords
Funding Information
- Natural Science Foundation of Heilongjiang Province (No. LH2022H007, No. LH2022H007, No. LH2022H007, No. LH2022H007, No. LH2022H007, No. LH2022H007, No. LH2022H007, No. LH2022H007, No. LH2022H007, No. LH2022H007)
- HMU Marshal Initiative Funding (No. HMUMIF-21007, No. HMUMIF-21007, No. HMUMIF-21007, No. HMUMIF-21007, No. HMUMIF-21007, No. HMUMIF-21007, No. HMUMIF-21007, No. HMUMIF-21007, No. HMUMIF-21007, No. HMUMIF-21007)
This publication has 36 references indexed in Scilit:
- A novel m6A reader Prrc2a controls oligodendroglial specification and myelinationCell Research, 2018
- Exploring the Impact of Single-Nucleotide Polymorphisms on TranslationFrontiers in Genetics, 2018
- The LINC01138 drives malignancies via activating arginine methyltransferase 5 in hepatocellular carcinomaNature Communications, 2018
- Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translationNature Cell Biology, 2018
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analysesNucleic Acids Research, 2017
- Cancer and liver cirrhosis: implications on prognosis and managementESMO Open, 2016
- Enhancer hijacking activates GFI1 family oncogenes in medulloblastomaNature, 2014
- GATA Transcription Factors and CancerGenes & Cancer, 2010
- SNPs: Impact on Gene Function and Phenotype2009
- AP-1 and colorectal cancerInflammopharmacology, 2005